CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, today reported that A. Ernest Whiton, its Chief Financial Officer and Vice President of Administration, has entered into a 10b5-1 sales plan for the sale of shares of ZOLL common stock over an approximate 12-month period. Under the plan, it is anticipated that approximately 40,000 shares will be sold. Sales under the plan are expected to commence in the third quarter of fiscal 2011. The shares to be sold will be acquired upon the exercise of portions of stock options which were granted to Mr. Whiton over the past five years. This new plan follows 10b5-1 sales plans entered into by Mr. Whiton in 2006, 2007, 2008 and 2010.
